A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients
Publication date
2006
Authors
Piersma, D.
Berns, E.M.J.J.
Verhoef-Post, M.
Uitterlinden, A.G.
Braakman, I.
Pols, H.A.P.
Themmen, A.P.N.
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
SDG 3 - Good Health and Well-being
Citation
Piersma, D, Berns, E M J J, Verhoef-Post, M, Uitterlinden, A G, Braakman, L J, Pols, H A P & Themmen, A P N 2006, 'A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients', Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 4, pp. 1470-1476.